Literature DB >> 29063272

The learning curve for endoscopic trans-sphenoidal resection of pituitary macroadenomas. A single institution experience, Leeds, UK.

James M W Robins1, Seyed A Alavi2, Atul K Tyagi2, Paul A Nix3, Tom M Wilson3, Nick I Phillips4.   

Abstract

BACKGROUND: The object of this study was to assess whether increasing operative experience results in greater endoscopic trans-sphenoidal resection of pituitary macroadenomas and lower complications.
METHODS: A retrospective single institution cohort study was performed. Subjects underwent endoscopic trans-sphenoidal resection of pituitary macroadenoma between July 2009 and July 2016 by three neurosurgeons. Following data collection, statistical analysis compared percentage of tumor resection and length of hospital stay (LOS) with experience. Complications including CSF leak are reported.
RESULTS: In total, 142 patients (87 male, 55 female) mean age 55.1 were included. Surgeon 1 performed 106 cases; surgeon 2 performed 23 cases; and surgeon 3 performed 13 cases. Mean pre-operative tumor volumes were 8.18 cm3, 6.52 cm3, and 3.47 cm3 and post-operative volumes were 2.21, 1.74, and 1.93 cm3 for surgeons 1, 2, and 3, respectively. Respective percentage resections were 74.3, 77.2, and 52.1%. Analysis demonstrated no difference in tumor resection with increasing experience for all three surgeons (p = 0.11, p = 0.17, and p = 0.26). Tumor consistency and cavernous sinus involvement did not appear to affect tumor resection. Mean LOS was 5 days, 4 days, and 3 days, respectively, with no significant correlation with experience for all three surgeons. Intraoperative CSF leak incidence was 19/106 (18%) for surgeon 1, 6/23(26%) for surgeon 2, and 2/13(15%) for surgeon 3. Primary closure rate was 96.3% and only three other complications occurred.
CONCLUSIONS: This study demonstrates that in our institution there is no statistically significant learning curve for the endoscopic resection of pituitary macroadenoma. However, there is a trend of improvement in tumor resection with experience for one surgeon. These findings suggest that the surgeons in our institution were capable of performing this procedure effectively with a low complication rate since adoption of the endoscopic technique in 2009.

Entities:  

Keywords:  CSF leak; Endoscopic; Learning curve; Macroadenoma; Pituitary adenoma; Trans-sphenoidal

Mesh:

Year:  2017        PMID: 29063272     DOI: 10.1007/s00701-017-3355-1

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  5 in total

1.  Transnasal Transsphenoidal Approach for Pituitary Tumors: An ENT Perspective.

Authors:  Vaibhav A Chandankhede; S K Singh; Ravi Roy; Sunil Goyal; M S Sridhar; M S Gill
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-02-11

2.  Cerebrospinal Fluid Leak after Transsphenoidal Surgery: A Systematic Review and Meta-analysis.

Authors:  Emma M H Slot; Rengin Sabaoglu; Eduard H J Voormolen; Eelco W Hoving; Tristan P C van Doormaal
Journal:  J Neurol Surg B Skull Base       Date:  2021-08-20

3.  Endoscopic transsphenoidal surgery for non-functioning pituitary adenoma: Learning curve and surgical results in a prospective series during initial experience.

Authors:  Julien Boetto; Irina Joitescu; Isabelle Raingeard; Sam Ng; Marine Le Corre; Nicolas Lonjon; Louis Crampette; Valentin Favier
Journal:  Front Surg       Date:  2022-08-02

4.  Clinical application of the "sellar barrier's concept" for predicting intraoperative CSF leak in endoscopic endonasal surgery for pituitary adenomas with a machine learning analysis.

Authors:  J F Villalonga; D Solari; R Cuocolo; V De Lucia; L Ugga; C Gragnaniello; J I Pailler; A Cervio; A Campero; L M Cavallo; P Cappabianca
Journal:  Front Surg       Date:  2022-09-08

5.  Post-operative volumes following endoscopic surgery for non-functioning pituitary macroadenomas are predictive of further intervention, but not endocrine outcomes.

Authors:  K Seejore; S A Alavi; S M Pearson; J M W Robins; B Alromhain; A Sheikh; P Nix; T Wilson; S M Orme; A Tyagi; N Phillips; R D Murray
Journal:  BMC Endocr Disord       Date:  2021-06-10       Impact factor: 2.763

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.